Palleon Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Palleon Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (NCT05259696) | Palleon Pharmaceuticals, Inc. | 2022-02-11 |
Track Palleon Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.